DC
LLY icon

Deschaine & Company’s Eli Lilly LLY Stock Holding History

Deschaine & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$1.23M Buy
14,702
+1,098
+8% +$83.7K 1.93% 15
2015
Q1 		$988K Sell
13,604
-899
-6% -$64K 1.63% 20
2014
Q4 		$1M Buy
+14,503
New +$979K 1.51% 22

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deschaine & Company's LLY Position: Q2 2015 in Review

Deschaine & Company increased its Eli Lilly (LLY) stake by 8.1% in Q2 2015, buying an estimated $83.7K and bringing the position to 14,702 shares worth $1.23M. The position accounts for 1.93% of the portfolio, ranked #15.

Deschaine & Company first reported a position in LLY in Q4 2014 and has held it in 3 quarters since. 1,139 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

  • Deschaine & Company held 14,702 shares of Eli Lilly worth $1.23M as of Q2 2015.
  • Deschaine & Company bought 1,098 Eli Lilly shares in Q2 2015, an estimated $83.7K.
  • Eli Lilly made up 1.93% of Deschaine & Company's portfolio in Q2 2015, its #15 holding.
  • Deschaine & Company first reported a position in Eli Lilly in Q4 2014 and has held it in 3 quarters since.
  • 1,139 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on Deschaine & Company's 13F filing for Q2 2015, filed 30 Jul 2015.